| Title, Synopsis and Publications | Investigators and Collaborators |
|
Tracking the impact of drug regulatory actions: Consumer health outcomes, risk-benefit issues and policy framework Women who had been prescribed a COX-2 prior to the September 2003 COX-2 discrediting event were selected from the Australian Longitudinal Study on Women’s Health. Qualitative in-depth telephone interviews were undertaken with ten women from the mid-aged (born 1946-51) and 10 from the older-aged (born 1921-26) to explore women’s reactions to the withdrawal of Vioxx and issuing of safety warnings regarding other COX-2s. Reactions to the discrediting event were largely undramatic. Women sought information from their general practitioner and made treatment decisions with the general practitioner based on that information. The media was the key source of information of the withdrawal event. Women were sceptical of the long term use of prescribed medicine while they were happy to be using complementary and alternative medicines. Women were using multiple medicines to manage their arthritis five years after this event. Return |
Prof Julie Byles Prof Lynne Parkinson Dr Evan Doran Dr Jane Robertson Mr Richard Gibson Dr Xenia Dolja-Gore Associate Professor Anne Young Dr Jennifer Stewart Williams Dr Andrew Searles Prof Glenn Salkeld Dr Paul Kowal Prof David Henry Ms Alison Gibberd Dr Melissa Harris Dr Debbi Long Ms Lisa Notley Dr Margaret Harris Dr Annette Moxey Dr Cassie Curryer Ms Payal Patel |